1. A limited access oral oxycodone paradigm produces physical dependence and mesocorticolimbic region-dependent increases in DeltaFosB expression without preference. (1st March 2022) Authors: Iyer, Vishakh; Woodward, Taylor J.; Pacheco, Romario; Hohmann, Andrea G. Journal: Neuropharmacology Issue: Volume 205(2022) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. A peripheral CB2 cannabinoid receptor mechanism suppresses chemotherapy-induced peripheral neuropathy: evidence from a CB2 reporter mouse. Issue 5 (24th May 2022) Authors: Lin, Xiaoyan; Xu, Zhili; Carey, Lawrence; Romero, Julian; Makriyannis, Alexandros; Hillard, Cecilia J.; Ruggiero, Elizabeth; Dockum, Marilyn; Houk, George; Mackie, Ken; Albrecht, Phillip J.; Rice, Frank L.; Hohmann, Andrea G. Journal: Pain Issue: Volume 163:Issue 5(2022) Page Start: 834 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. A protocol for the systematic review and meta-analysis of studies in which cannabinoids were tested for antinociceptive effects in animal models of pathological or injury-related persistent pain. (July 2019) Authors: Soliman, Nadia; Hohmann, Andrea G.; Haroutounian, Simon; Wever, Kimberley; Rice, Andrew S.C.; Finn, David P. Journal: Pain reports Issue: Volume 4:Number 4(2019) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Brain permeant and impermeant inhibitors of fatty-acid amide hydrolase suppress the development and maintenance of paclitaxel-induced neuropathic pain without producing tolerance or physical dependence in vivo and synergize with paclitaxel to reduce tumor cell line viability in vitro. (April 2019) Authors: Slivicki, Richard A.; Xu, Zhili; Mali, Sonali S.; Hohmann, Andrea G. Journal: Pharmacological research Issue: Volume 142(2019) Page Start: 267 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Cannabinoids, the endocannabinoid system, and pain: a review of preclinical studies. (July 2021) Authors: Finn, David P.; Haroutounian, Simon; Hohmann, Andrea G.; Krane, Elliot; Soliman, Nadia; Rice, Andrew S.C. Journal: Pain Issue: Volume 162(2021)Supplement 1 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Disruption of nNOS–NOS1AP protein–protein interactions suppresses neuropathic pain in mice. Issue 5 (May 2018) Authors: Lee, Wan-Hung; Li, Li-Li; Chawla, Aarti; Hudmon, Andy; Lai, Yvonne Y.; Courtney, Michael J.; Hohmann, Andrea G. Journal: Pain Issue: Volume 159:Issue 5(2018) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Inhibition of PSD95‐nNOS protein–protein interactions decreases morphine reward and relapse vulnerability in rats. (11th August 2022) Authors: Oliva, Idaira; Saberi, Shahin A.; Rangel‐Barajas, Claudia; Iyer, Vishakh; Bunner, Kendra D.; Lai, Yvonne Y.; Kulkarni, Pushkar M.; Garai, Sumanta; Thakur, Ganesh A.; Crystal, Jonathon D.; Rebec, George V.; Hohmann, Andrea G. Journal: Addiction biology Issue: Volume 27:Number 5(2022) Page Start: n/a Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. International Association for the Study of Pain Presidential Task Force on Cannabis and Cannabinoid Analgesia: research agenda on the use of cannabinoids, cannabis, and cannabis-based medicines for pain management. (July 2021) Authors: Haroutounian, Simon; Arendt-Nielsen, Lars; Belton, Joletta; Blyth, Fiona M.; Degenhardt, Louisa; Di Forti, Marta; Eccleston, Christopher; Finn, David P.; Finnerup, Nanna B.; Fisher, Emma; Fogarty, Alexandra E.; Gilron, Ian; Hohmann, Andrea G.; Kalso, Eija; Krane, Elliot; Mohiuddin, Mohammed; Moor... Journal: Pain Issue: Volume 162(2021)Supplement 1 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Negative allosteric modulation of CB1 cannabinoid receptor signaling suppresses opioid-mediated reward. (November 2022) Authors: Iyer, Vishakh; Rangel-Barajas, Claudia; Woodward, Taylor J.; Kulkarni, Abhijit; Cantwell, Lucas; Crystal, Jonathon D.; Mackie, Ken; Rebec, George V.; Thakur, Ganesh A.; Hohmann, Andrea G. Journal: Pharmacological research Issue: Volume 185(2022) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Peripheral sensory neuron CB2 cannabinoid receptors are necessary for both CB2-mediated antinociceptive efficacy and sparing of morphine tolerance in a mouse model of anti-retroviral toxic neuropathy. (January 2023) Authors: Carey, Lawrence M.; Xu, Zhili; Rajic, Gabriela; Makriyannis, Alexandros; Romero, Julian; Hillard, Cecilia; Mackie, Ken; Hohmann, Andrea G. Journal: Pharmacological research Issue: Volume 187(2023) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗